๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis

โœ Scribed by Ryuichi Yokote; Yoshiki Tokura; Fukumi Furukawa; Masahiro Takigawa


Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
418 KB
Volume
287
Category
Article
ISSN
0340-3696

No coin nor oath required. For personal study only.

โœฆ Synopsis


We investigated the in vitro responses to bacterial superantigens of peripheral blood mononuclear cells taken from patients with psoriasis (one arthropathic, two guttate and four chronic plaque type). We also analysed the relationship between the magnitude of the responses of peripheral blood mononuclear cells to bacterial exotoxins and the number of circulating T cells bearing V[~2 and Vl$3 regions. The proliferative response of peripheral blood mononuclear ceils to Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 was significantly higher in patients with active psoriasis than in normal subjects. An improvement in skin eruption was associated with a decrease in the lymphocyte response to one-half or one-third that of the active phase. There was no significant difference between patients with psoriasis and normal subjects in the percentage of V[~2-and V[~3-positive circulating T cells. The percentages of V[~2-positive and V~3-positive cells were not correlated with the levels of responsiveness to toxic shock syndrome toxin-1 and to Staphylococcal enterotoxin B, respectively. These findings suggest that the magnitude of responses of peripheral blood mononuclear cells to bacterial toxins does not depend on the number of T cells reactive with the relevant superantigen, but depends on the extent of skin lesions in psoriasis.


๐Ÿ“œ SIMILAR VOLUMES


Peripheral-blood mononuclear cell respon
โœ Haim Schupper; Paul Hayashi; James Scheffel; Sherri Acettuno; Teresa Paglieroni; ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 614 KB

Peripheral blood mononuclear cell proliferative responses in uitro to recombinant yeast or Escherichia coli hepatitis C virus fusion proteins were evaluated in 20 patients with chronic hepatitis C who were reactive for antibody to hepatitis C virus (on enzyme immunoassay, version 2.0, and a four-ant